Screening for natural and derived bio-active compounds in preclinical and clinical studies: One of the frontlines of fighting the coronaviruses pandemic — Shaden A.M. Khalifa (2020) | RDL Network
Screening for natural and derived bio-active compounds in preclinical and clinical studies: One of the frontlines of fighting the coronaviruses pandemic
Article 2020 en
Authors
SK
Shaden A.M. Khalifa
NY
Nermeen Yosri
ME
Mohamed F. El-Mallah
Abstract
1 min read
Natural compounds and their derivatives could be used for developing potent therapeutics with significant activity against SARS-COV-2, providing a promising frontline in the fighting against COVID-19.
Seyed Mohammad Reza Hashemian, Amirhossein Sheida, Mohammad Taghizadieh, Mohammad Yousef Memar, Michael R Hamblin, Hossein Bannazadeh Baghi, Javid Sadri Nahand, Zatollah Asemi, Hamed Mirzaei
Kamrul Hasan Chowdhury, Md. Riad Chowdhury, Shafi Mahmud, Abu Montakim Tareq, Nujhat Binte Hanif, Naureen Banu, A.S.M. Ali Reza, Talha Bin Emran, Jesus Simal Gandara
Stephen Fitzgerald, Gianluigi Rossi, Alison S. Low, Sean P. McAteer, Brian O’Keefe, David M. Findlay, Graeme Cameron, Peter Pollard, Peter T. R. Singleton, George Ponton, Andrew C. Singer, Kata Farkas, Davey L Jones, David W. Graham, Marcos Quintela‐Baluja, Christine Tait‐Burkard, David L. Gally, Rowland R. Kao, Alexander Corbishley
Discussion(0)
No comments yet. Be the first to comment.